Skip to main content
TipRanks
Go Ultimate75% OFF

Navicare Biotech Co., Ltd. (8472) Cash flow

Navicare Biotech Co., Ltd. Cash Flow

TW:8472's free cash flow for Q2 2026 was NT$-28.96M. For the 2026 fiscal year, TW:8472's free cash flow was increased by NT$0.00 and operating cash flow was NT$-28.96M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Mar 23Dec 21
NT$ -3.17MNT$ -63.49MNT$ -108.19MNT$ -68.41MNT$ -68.70M
NT$ 8.65MNT$ 49.10MNT$ 68.92MNT$ -157.56MNT$ 70.60M
NT$ 74.59MNT$ 7.07MNT$ 10.17MNT$ 205.06MNT$ -49.52M
NT$ 159.19MNT$ 79.00MNT$ 86.31MNT$ 115.42MNT$ 136.32M
NT$ -4.12MNT$ -72.22MNT$ -145.37MNT$ -474.62MNT$ -74.47M

Currency in TWD

Navicare Biotech Co., Ltd. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing